NCT01889199View on ClinicalTrials.gov

Androgen Excess as a Cause for Adipogenic Dysfunction in PCOS Women

PHASE2CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

July 6, 2023

Study Completion Date

July 6, 2023

Conditions
Polycystic Ovary Syndrome (PCOS)
Interventions
DRUG

Flutamide

Flutamide 125 mg orally each 28 day cycle for 6 cycles

OTHER

Placebo

Placebo orally each 28 day cycle for 6 cycles

Trial Locations (1)

90095-1740

UCaliforniaLA, Los Angeles

All Listed Sponsors
collaborator

Oregon Health and Science University

OTHER

lead

University of California, Los Angeles

OTHER

NCT01889199 - Androgen Excess as a Cause for Adipogenic Dysfunction in PCOS Women | Biotech Hunter | Biotech Hunter